Financial News
Kezar Life Sciences Inc (NQ: KZR )
0.6287
+0.0174
(+2.85%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Kezar Life Sciences Inc
![](https://cdn.benzinga.com/files/images/story/2024/08/14/pharma-lab-worker-ai.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240813917196/en/2214788/5/Kezar_Life_Sciences_logo_Business_Wire.jpg)
![](https://mms.businesswire.com/media/20240710548697/en/2181481/5/Kezar_Life_Sciences_logo_Business_Wire.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Analyst Expectations for Kezar Life Sciences's Future
November 27, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20240607753645/en/2154319/5/Kezar_Life_Sciences_logo_Business_Wire.jpg)
![](https://mms.businesswire.com/media/20240529724497/en/2143159/5/Kezar_Life_Sciences_logo_Business_Wire.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240509839405/en/2126158/5/Kezar_Life_Sciences_logo_Business_Wire.jpg)
![](https://mms.businesswire.com/media/20240506103935/en/2120948/5/Kezar_Life_Sciences_logo_Business_Wire.jpg)
![](https://mms.businesswire.com/media/20240408466993/en/2091516/5/Kezar_Life_Sciences_logo_Business_Wire.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/millionaire-stocks-to-buy-1600.png)
![](https://investorplace.com/wp-content/uploads/2022/03/penny-stocks-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240314902092/en/2066820/5/Kezar_Life_Sciences_logo_Business_Wire.jpg)
![](https://mms.businesswire.com/media/20240308295302/en/2059737/5/Kezar_Life_Sciences_logo_Business_Wire.jpg)
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
![](https://mms.businesswire.com/media/20240228522659/en/2048662/5/Kezar_Life_Sciences_logo_Business_Wire.jpg)
![](https://mms.businesswire.com/media/20240226328863/en/2045912/22/image001.jpg)
![](https://investorplace.com/wp-content/uploads/2022/07/penny-1600-1024x576.jpg)
![](https://investorplace.com/wp-content/uploads/2021/03/penny-stocks-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Lithium-Shutterstock.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/07/penny-stocks-finding-magnify.jpg)
![](https://mms.businesswire.com/media/20231113750324/en/1943659/5/Main-logo.jpg)
![](https://mms.businesswire.com/media/20231103988833/en/1934937/5/Kezar_Life_Sciences_logo_Business_Wire.jpg)
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
November 03, 2023
Via Business Wire
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20231009373517/en/1910814/5/Kezar_Life_Sciences_logo_Business_Wire.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20231003874621/en/1905674/5/Kezar_Life_Sciences_logo_Business_Wire.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023
October 05, 2023
Via Benzinga
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
Week In Review: Everest Acquires Novel Autoimmune Therapy In $132 Million Agreement
September 23, 2023
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.